
|Articles|October 1, 2012
Meaningful use Stage 2 rules up the ante for EHR incentive program
The recent release of the Centers for Medicare and Medicaid Services Final Rule for Stage 2 of the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program gives dermatologists a clear view of where the government initiative is steering you - and your patients. What lies ahead - eventually, even for those not participating in the program - is a new world of electronically connected practices and patients.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
2
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
3
Kyowa Kirin Takes Full Control of Rocatinlimab Program
4
Dermatology Times January 2026 Recap
5











